Have a personal or library account? Click to login
Treatment of hepatic and pulmonary hydatidosis with albendazole and praziquantel Cover

Treatment of hepatic and pulmonary hydatidosis with albendazole and praziquantel

By: G. Popova,  D. Vuchev and  K. Anichina  
Open Access
|Dec 2023

Figures & Tables

Fig. 1.

Liver hydatid cyst a) before treatment b) after 6 months combination therapy
Liver hydatid cyst a) before treatment b) after 6 months combination therapy

Fig. 2.

Liver hydatid cysts a) before treatment b) after 6 months combination therapy.
Liver hydatid cysts a) before treatment b) after 6 months combination therapy.

Fig. 3.

Pulmonary hydatid cysts a) before treatment b) after 3 months combination therapy.
Pulmonary hydatid cysts a) before treatment b) after 3 months combination therapy.

Patients with CE treated with albendazole and praziquantel_

Sex distribution12 males/8 females
Age12 – 70 (42.8 ± 7.8)
Number of liver cysts32
Number of lung cysts15
Number of cysts/patient1 – 5 (2.35 ± 0.59)
Size of cysts18 – 60 mm (37.8 ± 3.03)
Duration of the treatment with praziquantel2 – 6 months (3.8 ± 0.85)
Prior treatment with albendazolein 11 patients
Follow up12 – 48 months (32.4 ± 5.96)

Results of the treatment of hepatic hydatid cysts with albendazole and praziquantel_

Stage of liver hydatid cysts before treatment with praziquantelNumber of cysts
CureImprovementNo changeTotal
CE14217
CE2-112
CE3a21-3
CE3b142420
Total20 (62.6 %)6 (18.7 %)6 (18.7 %)32 (100 %)
DOI: https://doi.org/10.2478/helm-2023-0028 | Journal eISSN: 1336-9083 | Journal ISSN: 0440-6605
Language: English
Page range: 221 - 226
Submitted on: Jan 26, 2023
|
Accepted on: Jul 27, 2023
|
Published on: Dec 26, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2023 G. Popova, D. Vuchev, K. Anichina, published by Slovak Academy of Sciences, Institute of Parasitology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.